Newsroom


Please note that the Company does not update, correct or revise news releases after they have been issued. For the most current information about the Company, please refer to the most recent releases.
28

Media Contacts:
Don Murphy
Zeno Group, on behalf of Bausch + Lomb
917-817-2649
don.murphy@zenogroup.com


Bausch + Lomb Signs Agreement with IDOC to Expand Offering of Leading Contact Lenses and Specialty Vision Products

 

BRIDGEWATER, N.J., Feb. 28, 2018 – Bausch + Lomb, a leading global eye health company, announced an agreement with IDOC, the largest privately held alliance of independent doctors of optometry in the U.S. Under terms of the agreement, IDOC will offer its more than 3,000 members the Bausch + Lomb ULTRA® contact lenses, the fastest-growing family of monthly planned replacement contact lenses1, Biotrue® ONEday daily disposable contact lenses, the fastest-growing family of daily disposable hydrogels2, and brands from its Specialty Vision Products portfolio, including Bausch + Lomb Zenlens™ and Zen™ RC scleral lenses. IDOC members will also receive exclusive pricing and rebate programs, and exceptional support as the organization’s newest industry affiliate.

“Bausch + Lomb is proud to work with doctors and patients to develop innovative products designed for today’s needs, while anticipating the needs for the future. Through this collaboration, Bausch + Lomb expands the availability of our leading vision care products to more independent practices across the U.S. and provides them with the opportunity to fit more patients with our innovative portfolio of lenses, said John Ferris, vice president and general manager, U.S. contact lenses, Bausch + Lomb. “We are pleased to work with IDOC, an organization that shares our vision to provide practitioners and patients with more choices and innovation.”

“As an organization wholly committed to the growth and prosperity of independent optometrists, we are excited to collaborate with an industry leader such as Bausch + Lomb, to offer our members an extended line of advanced lens and specialty vision products from which their patients can truly benefit,” said Dave Brown, president and chief executive officer of IDOC. 


About Bausch + Lomb
Bausch + Lomb, a Valeant Pharmaceuticals International, Inc. company, is a leading global eye health organization that is solely focused on protecting, enhancing and restoring people's eyesight. Its core businesses include over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care products, ophthalmic surgical devices and instruments. Bausch + Lomb develops, manufactures and markets one of the most comprehensive product portfolios in our industry, which is available in more than 100 countries. 


About IDOC
IDOC is an alliance committed to the growth and long-term success of independent optometrists. Since 1999, IDOC has been providing eye care professionals a competitive advantage through strong vendor programs, business education and networking opportunities. In late 2015 IDOC LLC acquired Prima Eye Group and began providing consulting services for vision care professionals that include one-on-one consulting from a team of experts in optometric practice management and in specialized areas including marketing, human resources, and practice financial analysis. IDOC also hosts national and regional conferences along with roundtable groups to support educational and professional development. For more information about IDOC and its benefits and services, call (203) 989-3755 or visit www.idoc.net


®/™ are trademarks of Bausch & Lomb Incorporated or its affiliates. 
© 2018 Bausch & Lomb Incorporated.


References
1. Lens sales between January 2016-October 2017 among silicon hydrogel planned replacement contact lenses.
2. Lens sales between January 2016-October 2017 among traditional hydrogels. 

# # #


MTB.0101.USA.18
Actions: E-mail | Permalink |